These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7818527)

  • 1. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.
    Couvineau A; Gaudin P; Maoret JJ; Rouyer-Fessard C; Nicole P; Laburthe M
    Biochem Biophys Res Commun; 1995 Jan; 206(1):246-52. PubMed ID: 7818527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K; Nicole P; Couvineau A; Laburthe M
    Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.
    Gaudin P; Couvineau A; Maoret JJ; Rouyer-Fessard C; Laburthe M
    Biochem Biophys Res Commun; 1995 Jun; 211(3):901-8. PubMed ID: 7598720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
    Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
    Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
    Nicole P; Du K; Couvineau A; Laburthe M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):744-50. PubMed ID: 9454823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
    Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
    Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
    Gaudin P; Couvineau A; Maoret JJ; Rouyer-Fessard C; Laburthe M
    Ann N Y Acad Sci; 1996 Dec; 805():585-9. PubMed ID: 8993444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
    Nicole P; Du K; Couvineau A; Laburthe M
    Gastroenterol Clin Biol; 1997; 21(5):365-9. PubMed ID: 9208011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis of N-glycosylation sites in the human VIP 1 receptor.
    Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
    Ann N Y Acad Sci; 1996 Dec; 805():558-62. PubMed ID: 8993439
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM; Tams JW; Fahrenkrug J
    J Mol Neurosci; 2000 Jun; 14(3):137-46. PubMed ID: 10984189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.
    Perret J; Van Craenenbroeck M; Langer I; Vertongen P; Gregoire F; Robberecht P; Waelbroeck M
    Biochem J; 2002 Mar; 362(Pt 2):389-94. PubMed ID: 11853547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.
    Lins L; Couvineau A; Rouyer-Fessard C; Nicole P; Maoret JJ; Benhamed M; Brasseur R; Thomas A; Laburthe M
    J Biol Chem; 2001 Mar; 276(13):10153-60. PubMed ID: 11124960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
    Gaudin P; Couvineau A; Rouyer-Fessard C; Maoret JJ; Laburthe M
    Biochem Biophys Res Commun; 1999 Jan; 254(1):15-20. PubMed ID: 9920725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
    Gaudin P; Maoret JJ; Couvineau A; Rouyer-Fessard C; Laburthe M
    J Biol Chem; 1998 Feb; 273(9):4990-6. PubMed ID: 9478946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
    Wilmen A; Van Eyll B; Göke B; Göke R
    Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.
    Couvineau A; Rouyer-Fessard C; Darmoul D; Maoret JJ; Carrero I; Ogier-Denis E; Laburthe M
    Biochem Biophys Res Commun; 1994 Apr; 200(2):769-76. PubMed ID: 8179610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of the human vasoactive intestinal peptide receptor.
    Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.
    Solano RM; Langer I; Perret J; Vertongen P; Juarranz MG; Robberecht P; Waelbroeck M
    J Biol Chem; 2001 Jan; 276(2):1084-8. PubMed ID: 11013258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin.
    Wulff B; Møller Knudsen S; Adelhorst K; Fahrenkrug J
    FEBS Lett; 1997 Aug; 413(3):405-8. PubMed ID: 9303545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.